BLFS News Alert Biolife Solutions (BLFS) 1.79 12/25/2014 10:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biolife Solutions (BLFS) 1.79 $BLFS

BioLife Solutions Sets Date for Annual Meeting of Stockholders
PR Newswire - Wed Dec 24, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced that it will hold its 2015 Annual Meeting of Stockholders on May 4, 2015 (the "Annual Meeting" .
BLFS: 1.79 (-0.02)

BioLife Solutions Names Pharmaceutical Industry Expert Kevin O'Donnell as Vice President, Cold Chain Standards, Practices & Compliance
PR Newswire - Tue Dec 23, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced that pharmaceutical industry cold chain expert Kevin O'Donnell has joined the Company as Vice President, Cold Chain Standards, Practices & Compliance.
BLFS: 1.79 (-0.02)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 11:45AM CST

GLOG: 20.40 (-0.98), MILL: 1.23 (-0.07), LPHI: 0.70 (+0.02), NEOT: 6.65 (+0.25), BOBE: 50.58 (-0.04), FES: 1.19 (-0.01), REDF: 2.09 (unch), NKTR: 15.02 (+0.23), PRTO: 10.40 (+0.17), CANF: 3.70 (+0.01), CALI: 1.19 (+0.05), TRT: 2.92 (unch), SQNM: 3.59 (-0.01), CARB: 14.54 (+0.94), SEED: 1.33 (-0.03), BLFS: 1.79 (-0.02), DGLY: 15.62 (+0.82), TCCO: 4.96 (-0.04), ALCO: 49.88 (-0.50), PBYI: 189.96 (+0.12)

BioLife Solutions to Present at the LD Micro "Main Event" Investor Conference on Wednesday, December 3, 2014
PR Newswire - Tue Nov 25, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced that it will be presenting at the LD MICRO "Main Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014. The conference will be held at the Luxe Sunset Bel Air Hotel, which is located at 11461 Sunset Boulevard in Los Angeles, California.
BLFS: 1.79 (-0.02)

BUYINS.NET Issues BioLife Solutions (BLFS) SqueezeTrigger Report
M2 - Mon Nov 24, 7:09AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated trading coverage on BioLife Solutions, Inc., (NASDAQ: BLFS) after releasing the latest short sale data through November 21, 2014. The total aggregate number of shares shorted since August 2009 is approximately 3.4 million shares, adjusted for a 1 for 14 reverse split that occurred on January 29, 2014. Approximately 26.04% of daily trading volume is short selling. The SqueezeTrigger price for all BLFS shares shorted is $3.29. A short squeeze is expected to begin when shares of BLFS close above the $3.29 SqueezeTrigger price.
BLFS: 1.79 (-0.02)

BioLife Solutions Launches Two New Product Packaging Options for BloodStor® and CryoStor® Freeze Media
PR Newswire - Mon Nov 17, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced it has launched two new improved packaging options for its BloodStor and CryoStor cryopreservation freeze media products.
BLFS: 1.79 (-0.02)

BioLife Solutions Named to Deloitte's 2014 Technology Fast 500(TM) List of Fastest Growing Companies in North America
PR Newswire - Thu Nov 13, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced it has been named to the Deloitte 2014 Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. This is the second consecutive year BioLife has been recognized for high growth.
BLFS: 1.79 (-0.02)

BioLife Solutions' (BLFS) CEO Mike Rice on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 11, 10:23PM CST

BLFS: 1.79 (-0.02)

Update: BioLife Q3 Earnings
Trevor Lowenthal - at Seeking Alpha - Fri Nov 07, 5:00AM CST

BLFS: 1.79 (-0.02)

BioLife Solutions misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:34PM CST

BLFS: 1.79 (-0.02)

BioLife Solutions Announces Third Quarter 2014 Results
PR Newswire - Thu Nov 06, 3:05PM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced financial results for the third quarter of 2014.
BLFS: 1.79 (-0.02)

BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014
PR Newswire - Thu Oct 30, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced today that the Company's third quarter 2014 financial results will be released on Thursday, November 6, 2014, and that the Company will host a conference call and live webcast at 1:30 p.m. PST that afternoon. Management will provide an overview of the Company's financial results and a general business update.
BLFS: 1.79 (-0.02)

RoosterBio Selects BioLife Solutions CryoStor® to Commercialize Human Bone Marrow-Derived Stem Cells
PR Newswire - Tue Oct 21, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , announced today that Frederick, MD based RoosterBio, Inc., has adopted the Company's CryoStor clinical grade cryopreservation freeze media to commercialize RoosterBio's human bone marrow-derived, adult mesenchymal stem cell (hMSC) products. RoosterBio's hMSC products are being used by researchers throughout the world to accelerate the development of cellular therapies and engineered tissues targeting major diseases and disorders affecting millions of patients each year.
BLFS: 1.79 (-0.02)

BioLife Solutions Biopreservation Media Products Used at NeoStem Subsidiary Progenitor Cell Therapy
PR Newswire - Tue Oct 14, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today provided an update on use of the Company's HypoThermosol storage/shipping media and CryoStor cryopreservation freeze media by Progenitor Cell Therapy, LLC (PCT), a wholly owned subsidiary of NeoStem, Inc., (NASDAQ: NBS) a leader in the emerging cellular therapy field.
NBS: 3.27 (+0.02), BLFS: 1.79 (-0.02)

BioLife Solutions Announces Preliminary Revenue for Q3 2014 of $1.2 Million
PR Newswire - Mon Oct 06, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced preliminary revenue of $1.2 million for the third quarter of 2014. Revenue from sales of BioLife's core proprietary biopreservation media products was $1.2 million, representing 15% sequential growth over the second quarter of 2014, and an increase of 24% over the same quarter in 2013.
BLFS: 1.79 (-0.02)

BioLife Solutions Forms biologistex CCM(SM) Joint Venture with SAVSU® Technologies to Market Intelligent, Controlled Temperature Containers for Biologics
PR Newswire - Tue Sep 30, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced the formation of a joint venture under the brand name of biologistex Cold Chain Management ("CCM" , a play on biologistics, defined as the processes, tools, and data used to monitor and manage the movement of biologic materials such as vaccines, cells, tissues, and organs across time and space.
BLFS: 1.79 (-0.02)

BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board
PR Newswire - Tue Sep 23, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced two new additions to its Scientific Advisory Board. The new members are Jason Acker, PhD, and Anthony Davies, PhD.
BLFS: 1.79 (-0.02)

BioLife Solutions To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City And The Aegis Healthcare & Technology Conference In Las Vegas
PR Newswire - Mon Sep 08, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , announced that Mike Rice, CEO, is scheduled to present at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, and at the Aegis Healthcare & Technology Conference, hosted by Aegis Capital Corp.
BLFS: 1.79 (-0.02)

BioLife Solutions CryoStor® AND HypoThermosol® Now Embedded In 130 Regenerative Medicine Clinical Trials
PR Newswire - Mon Aug 25, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today provided an update on adoption of the Company's proprietary HypoThermosol and CryoStor biopreservation media products. Management estimates that BioLife's products are now incorporated into the collection, storage, shipping, freezing, and/or patient administration processes of at least 130 customer clinical trials or novel cell-based regenerative medicine products and therapies.
BLFS: 1.79 (-0.02)

BioLife Solutions Announces Second Quarter 2014 Results
PR Newswire - Thu Aug 07, 3:05PM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company" , today announced financial results for the second quarter of 2014.
BLFS: 1.79 (-0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Cloud Security’s $26.8 Billion Test Is All About Execution

Updated Category News Views 65

A cloud dashboard that spits out ten thousand alerts is not protection; it is an expensive way to make a security team miserable. That frustration sits right in the middle of Frost & Sullivan’s projection that global cloud security revenue will climb from $8.4 billion in 2025 to $26.8 billion by 2031, a 21.4% compound annual growth rate. The number is hefty, no...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 86

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 133

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 121

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 87

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading

Top 5 Most Recently Viewed Articles

American Teachers Alliance Initiates Empowering Programs for Students

Updated Category News Views 143

Empowering Future Educators with College Chapters In a progressive move to inspire and support the upcoming generation of teachers, the American Teachers Alliance (ATA) has launched a significant initiative aimed at engaging college students across universities. This initiative introduces college student chapters, fostering a community where aspiring educators can enhance...

Continue Reading
Enhancing Enterprise Collaboration: Progress ShareFile and Microsoft 365

Updated Category News Views 190

Introduction to Progress ShareFile's New Features Progress, a leading provider of AI-driven digital experience and infrastructure software, is excited to announce significant advancements to its ShareFile platform. The recent updates mark a transformative leap in how enterprises collaborate using Microsoft 365, empowering teams to work more securely and efficiently. Deep...

Continue Reading
Shareholder Alert: Investigations on Major Mergers for 2025

Updated Category News Views 314

Investigating Significant Mergers in 2025 In the financial landscape, the merging of companies can significantly impact shareholders. Recognizing the importance of every shareholder's voice, we delve into several notable mergers that are under scrutiny as we approach votes critical to shareholders. As many companies opt for merger routes, understanding the implications of...

Continue Reading
Explore the Vibrant Daylight Shows Series in NYC's Hotspots

Updated Category News Views 181

Unveiling the Daylight Shows at Daylight Studio Experience the vibrant world of creativity at Daylight Studio, a prominent event venue nestled in two of New York City's most dynamic areas, Hudson Yards and Flatiron. With years of experience in supporting film, fashion, and artistic endeavors, Daylight Studio has secured its place as a go-to location for creatives and...

Continue Reading
Ventyx Biosciences Begins Phase 2a Trial for Parkinson’s Treatment

Updated Category News Views 138

Ventyx Biosciences Begins Phase 2a Trial for VTX3232 Ventyx Biosciences, Inc. (Nasdaq: VTYX), a company focused on creating innovative oral treatments for various inflammatory diseases, has announced the start of dosing for its Phase 2a clinical trial of VTX3232. This important trial is centered on individuals who have been diagnosed with the early stages of Parkinson’s...

Continue Reading